NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
11.32
+0.23 (2.07%)
At close: Feb 6, 2026, 4:00 PM EST
11.10
-0.22 (-1.94%)
After-hours: Feb 6, 2026, 4:00 PM EST
NextCure Market Cap
NextCure has a market cap or net worth of $39.68 million as of February 6, 2026. Its market cap has increased by 77.90% in one year.
Market Cap
39.68M
Enterprise Value
15.96M
1-Year Change
77.90%
Ranking
Category
Stock Price
$11.32
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $39.68M, a decrease of -90.91%. That is a compound annual growth rate of -29.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 38.88M | -21.85% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 44.07M |
| Estrella Immunopharma | 43.72M |
| Aligos Therapeutics | 43.51M |
| CervoMed | 43.21M |
| Plus Therapeutics | 42.83M |
| CEL-SCI | 42.13M |
| Apollomics | 41.81M |
| Lisata Therapeutics | 41.55M |